Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New candidate cancer therapeutics designed at CSIR

July 9, 2012

Siena Biotech patents new SMO receptor antagonists

July 9, 2012

Researchers at Piramal Life Sciences prepare new PI3Kalpha inhibitors

July 9, 2012

New models of kidney cancer developed in U.S.

July 6, 2012

Health Canada approves Jakavi for treatment of patients with myelofibrosis

July 6, 2012

Debio-0932 shows promising activity in patients with advanced solid tumors

July 6, 2012

Epizyme synthesizes novel DOT1-like protein inhibitors

July 6, 2012

Roche divulges novel Mdm2/p53 interaction inhibitors

July 6, 2012

Phase I/Ib trial evaluates AUY-922 alone and with bortezomib

July 6, 2012

Encouraging phase II results presented on PD-0332991

July 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...